EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients

Michael Prodanuk iD, Kathryn Timberlake, Alicia Koo, Yogi Chopra, Donna A Wall iD, Michelle Science iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Michael Prodanuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Levofloxacin, Hematopoietic Stem Cell Transplantation, Anti-Bacterial Agents, Antibiotic Prophylaxis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levofloxacin prophylaxis during periods of neutropenia in pediatric hematopoietic stem cell transplant (HSCT) may reduce the number of febrile episodes and use of empiric intravenous antibiotics (EIA); however, the literature is conflicting. This retrospective review compared EIA use before and after implementation of levofloxacin prophylaxis at a children's hospital. Levofloxacin prophylaxis was associated with reduced use of certain EIA; however, did not reduce the number of positive blood cultures or clinical deteriorations. Therefore, levofloxacin prophylaxis may have implications for the stewardship of broad‐spectrum intravenous antibiotics used in pediatric HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinHematopoietic Stem Cell TransplantationAnti-Bacterial AgentsAntibiotic ProphylaxisHumansRetrospective StudiesChildMaleFemaleChild, PreschoolAdolescentInfantNeutropeniaAdministration, Intravenous

Stichwörter der Autor:innen

antimicrobial stewardshiphematopoietic stem cell transplantlevofloxacinpediatricsprophylaxis

Substanzen

LevofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Michael Prodanuk, Donna A Wall, Michelle Science

Zitieren

APA

Prodanuk, M., Timberlake, K., Koo, A., Chopra, Y., Wall, D. A., & Science, M. (2024). The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31059

Vancouver

Prodanuk M, Timberlake K, Koo A, Chopra Y, Wall DA, Science M. The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31059

BibTeX
@article{Prodanuk2024,
  author = {Prodanuk, Michael and Timberlake, Kathryn and Koo, Alicia and Chopra, Yogi and Wall, Donna A and Science, Michelle},
  title = {The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31059}
}
Kostenlos starten →